GLI1 and plasma cell myeloma: In multiple myeloma CSCs, it was shown that SMO and Gli1 were highly expressed in comparison to non-CSCs, and activation of HH signaling by HH ligands promoted multiple myeloma CSC's expansion, whereas inhibition of the HH signaling markedly blocked CSC's clonal expansion [54].